ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

HU

Hospital Universitario 12 de Octubre at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Hospital Universitario 12 de Octubre takes part in 26 sessions at ESMO 2026 in Madrid, its home city. Its program spans several cancers, including breast, lung and gynaecological cancers, alongside precision oncology. Specific topics include treatment choices for advanced breast cancer and monitoring bladder cancer without invasive procedures.

OrganizationESMO 2026 Attendance
HU
Hospital Universitario 12 de Octubre
Madrid, Spain
Cancer centre & hospital
Public university hospital of the Madrid regional health service, affiliated with Complutense University, in Madrid, Spain.
Poster
Fri Oct 23
13:00–15:00
Diagnostic and treatment pathway experience in primary brain tumours: A cross-sectional analysis
ePoster session 4
Sarcoma, CNS, head & neck and rare cancers
Poster
Fri Oct 23
13:00–15:00
Independent validation of TNBCDX in early-stage triple-negative breast cancer in a real-world cohort
ePoster session 23
Breast cancerBiomarkers & precision oncology
Chair
Fri Oct 23
13:30–15:00
SCLC: Can we finally tackle it?
with Hanyang University
Lung & thoracic cancers
Poster
Fri Oct 23
15:15–16:00
Satellite
Fri Oct 23
18:15–19:45
Satellite
Fri Oct 23
18:15–18:20
Welcome and Introductions
Menarini Stemline - ESR1-mutated Advanced Breast Cancer: A Transforming Treatment Landscape
Breast cancerBiomarkers & precision oncology
Satellite
Fri Oct 23
18:20–18:45
Post-CDK4/6i Progression in ER+/HER2– mBC: The EU Landscape in 2026
Menarini Stemline - ESR1-mutated Advanced Breast Cancer: A Transforming Treatment Landscape
Breast cancerBiomarkers & precision oncology
Satellite
Fri Oct 23
18:35–18:50
Interpreting evidence for durable survival in dMMR/MSI-H EC
GSK - From evidence to clinical practice: Long-term survival outcomes in advanced endometrial cancer
Gynaecological cancers
Satellite
Fri Oct 23
19:00–19:40
A new eye on earlier stages in bladder cancer: Redefining bladder preservation in HR NMIBC
Johnson & Johnson - Personalizing GU Oncology Treatments: Maximizing Outcomes, Preserving Quality of Life · with Amsterdam UMC, San Raffaele Hospital
Genitourinary cancers
Satellite
Fri Oct 23
19:15–19:40
Mapping change: Evolving clinical practice and conversations
GSK - From evidence to clinical practice: Long-term survival outcomes in advanced endometrial cancer · with NYU Langone Perlmutter Cancer Center, Oncology Institute of Southern Switzerland (IOSI)
Gynaecological cancers
Satellite
Fri Oct 23
19:35–19:45
Summary and Closing
Menarini Stemline - ESR1-mutated Advanced Breast Cancer: A Transforming Treatment Landscape
Breast cancerBiomarkers & precision oncology
Chair
Sat Oct 24
14:45–15:45
Talk
Sat Oct 24
15:30–15:45
Neuroendocrine tumors (NET)
Emerging therapies in endocrine and neuroendocrine neoplasms
Sarcoma, CNS, head & neck and rare cancers
Satellite
Sat Oct 24
18:35–18:55
HER2-mutant NSCLC: Transforming precision medicine into clinical reality
Boehringer Ingelheim International GmbH - HER2 and DLL3: Shaping the next generation of targeted cancer therapy
Lung & thoracic cancers
Satellite
Sat Oct 24
19:25–19:45
Establishing the present of clinical practice
PharmaMar - More time for patients: Reframing the course of ES-SCLC
Lung & thoracic cancers
Chair
Sun Oct 25
08:30–10:00
Rapid oral 2: NSCLC, metastatic
with Centre Léon Bérard, Gustave Roussy
Lung & thoracic cancers
Abstract
Sun Oct 25
08:40–08:52
Invited Discussant LBA76 and 2616RO
Rapid oral 2: NSCLC, metastatic
Lung & thoracic cancers
Talk
Sun Oct 25
09:10–09:50
The Leadership Futures Arena
From visibility to power: Designing the next generation of oncology leadership · with Metropolitan Hospital, Lausanne University Hospital (CHUV), Agios Andreas General Hospital of Patras +2 more
Abstract
Sun Oct 25
10:20–10:25
Poster
Sun Oct 25
12:00–12:45
Non-invasive monitoring for severe neutropenia: Optimal timing for preventing febrile neutropenia and its clinical impact (PC001-005 study group)
Sunday Poster Display session 1
Haematological malignanciesNursing & supportive care
Poster
Sun Oct 25
12:00–12:45
Poster
Sun Oct 25
12:00–12:45
Chair
Sun Oct 25
14:45–16:15
Key challenges in managing patients with metastatic breast cancer
with Medical University of Vienna
Breast cancer
Chair
Sun Oct 25
15:00–16:00
YO Medical Students session: ESMO for medical students and young physicians
with Hospital Clínico Universitario de Valencia
Talk
Sun Oct 25
15:35–16:00
Turning the corner: Personalized therapy for triple-negative breast cancer becomes a reality
Key challenges in managing patients with metastatic breast cancer
Breast cancer
Satellite
Sun Oct 25
19:00–19:10
Digital pathology and AI: How do we implement them and show clinical impact?
MSD - Is the precision medicine ecosystem ready? Overcoming diagnostic barriers in oncology
Biomarkers & precision oncology
Talk
Mon Oct 26
08:30–08:50
Translating new ideas into trials
YO Forum: Thinking beyond traditional research ideas
Poster
Mon Oct 26
12:00–12:45
CTNNB1 mutations in non-small cell lung cancer (NSCLC): Clinical outcomes and response to targeted therapy in a multicenter real-world cohort
Monday Poster Display session 5
Lung & thoracic cancersBiomarkers & precision oncology
Poster
Mon Oct 26
12:00–12:45
Clinical management and treatment tolerance in older patients with advanced ovarian cancer: ReWiGO
Monday Poster Display session 1
Gynaecological cancers
Poster
Mon Oct 26
12:00–12:45
FIT-NETs: Effects of an exercise program on physical and emotional well-being in patients with advanced digestive or unknown primary G1-2 neuroendocrine tumors (NETs)
Monday Poster Display session 3
Sarcoma, CNS, head & neck and rare cancersNursing & supportive care
Poster
Mon Oct 26
12:00–12:45
Systemic therapy in advanced gastric neuroendocrine neoplasms (G-NENs): Real-world evidence from the R-GETNE National Registry (G-NENCARE)
Monday Poster Display session 3
Sarcoma, CNS, head & neck and rare cancers
Satellite
Mon Oct 26
13:00–14:30
Satellite
Mon Oct 26
13:00–13:05
Welcome and Introduction
Daiichi Sankyo and MSD - Shaping the Future of ES-SCLC: Pioneering Treatment Strategies
Lung & thoracic cancers
Satellite
Mon Oct 26
13:55–14:15
Improving Patient Outcomes: Lessons from Other Indications
Daiichi Sankyo and MSD - Shaping the Future of ES-SCLC: Pioneering Treatment Strategies
Lung & thoracic cancers

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Hospital Universitario 12 de Octubre

Tell us what you sell and we’ll find the people at Hospital Universitario 12 de Octubre most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction